Norwegian Lung Cancer Biobank (NLCB) and Bergen cohort

doi:doi:10.57702/71hmof9h

You're currently viewing an old version of this dataset. To see the current version, click here.

Norwegian Lung Cancer Biobank (NLCB) and Bergen cohort

The Norwegian Lung Cancer Biobank (NLCB) cohort and the Bergen cohort were used to create the proposed model. The NLCB cohort includes histopathological, cytological, biomarker, and clinical follow-up data from patients with suspected lung cancer diagnosed in Central Norway after 2006. The Bergen Cohort comprises 438 surgically treated NSCLC patients diagnosed at Haukeland University Hospital, Bergen, Norway from 1993–2010.

Data and Resources

Original MetadataJSON
The json representation of the dataset with its distributions based on DCAT.
Explore
- Preview
- Download

Cite this as

Soroush Oskouei, Marit Valla, Andr ´e Pedersen, Erik Smistad, Vibeke Grotnes Dale, Maren Høibø, Sissel Gyrid Freim Wahl, Mats Dehli Haugum, Thomas Langø, Maria Paula Ramnefjell, Lars Andreas Akslen, Gabriel Kiss, Hanne Sorger (2024). Dataset: Norwegian Lung Cancer Biobank (NLCB) and Bergen cohort. https://doi.org/10.57702/71hmof9h

DOI retrieved: December 3, 2024

Additional Info

Field	Value
Created	December 3, 2024
Last update	December 3, 2024
Author	Soroush Oskouei
More Authors	Marit Valla Andr ´e Pedersen Erik Smistad Vibeke Grotnes Dale Maren Høibø Sissel Gyrid Freim Wahl Mats Dehli Haugum Thomas Langø Maria Paula Ramnefjell Lars Andreas Akslen Gabriel Kiss Hanne Sorger